Trillium Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Industry: Pharmaceutical Preparations
Location: 2488 Dunwin Drive, Mississauga, Ontario, Canada

There are no Buy or Sell transactions made by insiders since 3/4/2024

Trillium Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Paolo Pucci	Director				Nov 17, 2021
Scott Myers	Director				Nov 17, 2021
Paul Edward Walker	Director				Nov 17, 2021
Luke M. Beshar	Director				Nov 17, 2021
James T. Parsons	Chief Financial Officer				Nov 17, 2021
Michael E. Kamarck	Director				Nov 17, 2021
Robert Uger	Chief Scientific Officer				Nov 17, 2021
Rosemary Harrison	Title: Senior Vice President, Corporate Development and Strategy				Nov 17, 2021
Jan Skvarka	President and CEO, Director				Nov 17, 2021
Helen Tayton Martin	Director				Nov 17, 2021
Penka Petrova	Chief Development Officer				Nov 17, 2021
Ingmar Bruns	Chief Medical Officer				Nov 17, 2021
Catherine J. Mackey	Director				Nov 17, 2021
Benjamin Looker	General Counsel				Nov 17, 2021

Showing 1 to 14 of 14 entries

Recent Insider Transactions by Companies or Individuals for Trillium Therapeutics Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.